WO2021201792A1 - Matériau composite formé à l'aide de bore au cours de la production d'un matériau de base en polyuréthane - Google Patents

Matériau composite formé à l'aide de bore au cours de la production d'un matériau de base en polyuréthane Download PDF

Info

Publication number
WO2021201792A1
WO2021201792A1 PCT/TR2020/050461 TR2020050461W WO2021201792A1 WO 2021201792 A1 WO2021201792 A1 WO 2021201792A1 TR 2020050461 W TR2020050461 W TR 2020050461W WO 2021201792 A1 WO2021201792 A1 WO 2021201792A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
composite material
boron compound
polyurethane
base material
Prior art date
Application number
PCT/TR2020/050461
Other languages
English (en)
Inventor
Emir TEMİZKAN
Gülden EROĞLU
Hüseyin DELİGÖZ
Original Assignee
Safaş Saf Plasti̇k Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Safaş Saf Plasti̇k Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ filed Critical Safaş Saf Plasti̇k Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇
Priority to EP20735248.5A priority Critical patent/EP4127043A1/fr
Publication of WO2021201792A1 publication Critical patent/WO2021201792A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/0066—Use of inorganic compounding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08—Processes
    • C08G18/16—Catalysts
    • C08G18/18—Catalysts containing secondary or tertiary amines or salts thereof
    • C08G18/20—Heterocyclic amines; Salts thereof
    • C08G18/2045—Heterocyclic amines; Salts thereof containing condensed heterocyclic rings
    • C08G18/2063—Heterocyclic amines; Salts thereof containing condensed heterocyclic rings having two nitrogen atoms in the condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08—Processes
    • C08G18/16—Catalysts
    • C08G18/22—Catalysts containing metal compounds
    • C08G18/24—Catalysts containing metal compounds of tin
    • C08G18/244—Catalysts containing metal compounds of tin tin salts of carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30—Low-molecular-weight compounds
    • C08G18/32—Polyhydroxy compounds; Polyamines; Hydroxyamines
    • C08G18/3271—Hydroxyamines
    • C08G18/3275—Hydroxyamines containing two hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/30—Low-molecular-weight compounds
    • C08G18/32—Polyhydroxy compounds; Polyamines; Hydroxyamines
    • C08G18/3271—Hydroxyamines
    • C08G18/3278—Hydroxyamines containing at least three hydroxy groups
    • C08G18/3281—Hydroxyamines containing at least three hydroxy groups containing three hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/65—Low-molecular-weight compounds having active hydrogen with high-molecular-weight compounds having active hydrogen
    • C08G18/66—Compounds of groups C08G18/42, C08G18/48, or C08G18/52
    • C08G18/6666—Compounds of group C08G18/48 or C08G18/52
    • C08G18/667—Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38
    • C08G18/6681—Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/32 or C08G18/3271 and/or polyamines of C08G18/38
    • C08G18/6688—Compounds of group C08G18/48 or C08G18/52 with compounds of group C08G18/32 or polyamines of C08G18/38 with compounds of group C08G18/32 or C08G18/3271 and/or polyamines of C08G18/38 with compounds of group C08G18/3271
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/74—Polyisocyanates or polyisothiocyanates cyclic
    • C08G18/76—Polyisocyanates or polyisothiocyanates cyclic aromatic
    • C08G18/7614—Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring
    • C08G18/7621—Polyisocyanates or polyisothiocyanates cyclic aromatic containing only one aromatic ring being toluene diisocyanate including isomer mixtures
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/04—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent
    • C08J9/12—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent
    • C08J9/14—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof using blowing gases generated by a previously added blowing agent by a physical blowing agent organic
    • C08J9/143—Halogen containing compounds
    • C08J9/144—Halogen containing compounds containing carbon, halogen and hydrogen only
    • C08J9/145—Halogen containing compounds containing carbon, halogen and hydrogen only only chlorine as halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/38—Boron-containing compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2101/00—Manufacture of cellular products
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G2110/00—Foam properties
    • C08G2110/0083—Foam properties prepared using water as the sole blowing agent
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2203/00—Foams characterized by the expanding agent
    • C08J2203/14—Saturated hydrocarbons, e.g. butane; Unspecified hydrocarbons
    • C08J2203/142—Halogenated saturated hydrocarbons, e.g. H3C-CF3
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2207/00—Foams characterised by their intended use
    • C08J2207/10—Medical applications, e.g. biocompatible scaffolds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2207/00—Foams characterised by their intended use
    • C08J2207/12—Sanitary use, e.g. diapers, napkins or bandages
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
    • C08J2375/04—Polyurethanes
    • C08J2375/08—Polyurethanes from polyethers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K3/00—Use of inorganic substances as compounding ingredients
    • C08K3/38—Boron-containing compounds
    • C08K2003/387—Borates

Definitions

  • the invention relates to a composite material formed by using boron during production of a polyurethane base material.
  • wound healing materials produced using Boron are available, which materials are obtained by adding boron to the structures such as collagen, hydrogel. Wound healing materials formed by adding Boron to a polyurethane material are not included in the state of the art.
  • the patent document no. TR 2019/12225 discloses polyurethane foam produced for hygiene.
  • the amount of boron added to the foam contains 10% borax.
  • Said patent document disclosed a composite material obtained by adding 9-35% boron compound to a polyol during polyurethane production. Therefore, the ratio of the boron compound in the composite material is provided to be 5-23%. Said patent document does not disclose the wound healing property of the composite material.
  • the patent US8147857 describes the production of a polyurethane gel as an antiseptic wound dressing.
  • the present invention relates to the use of a boron compound to enable the flexible polyurethane foam to gain wound-healing properties. Said document does not disclose the production of the polyurethane foam material.
  • the wound healing property of said polyurethane gel is not mentioned.
  • boron was added to a wide variety of materials. During this addition, boron is added to the foam by an impregnation method, but after this method, the foam loses its original property. The pores of the foam which is normally flexible, is an open cell foam and is air-permeable are closed after the boron impregnation, thus the permeability property is lost and the foam hardens. This technical problem in the state of the art needs to be overcome.
  • the object of the invention is to produce a composite material by adding boron to flexible polyurethane foam.
  • Said composite material is used in the fields such as medical, cleaning, mattress, upholstery (sofa), bras, and shoe insoles.
  • the composite material used for medical purposes is used to heal wounds.
  • the composite material formed by adding boron to the flexible polyurethane foam does not lose its flexible and air-permeable properties. Therefore, in foams which are normally flexible, are open cell foams and are air-permeable, the pores of the composite material obtained after the addition of a boron compound during the production of a base material are not closed, so the permeability is not lost and the foam does nor harden.
  • the amount of boron added to the material is important to have specific values. This value should be at least 40%.
  • Figure 1 is a schematic perspective view of a composite material according to the invention.
  • the invention relates to a composite material (1) formed by adding a boron compound (1.2) to a base material (1.1). Said composite material (1) will be used especially for medical purposes and has a wound healing property.
  • the composite material (1) of the invention includes a base material (1.1) and a boron compound (1.2) added to said base material (1.1) at a predetermined ratio.
  • Said base material (2) is flexible and is, but not limited to, a polyurethane material in a preferred embodiment of the invention.
  • the polyurethane material is preferably, but not limited to, a foam.
  • the boron compound (1.2) is added to the base material (1.1) during the production of the base material (1.1). Boron Compound (1.2) is not impregnated to Polyurethane base materials (1.1) in the state of the art with the invention. The boron compound (1.2) is added to the base material (1.1) during the production of the base material ( 1.1 ), so that a composite material (1) is obtained.
  • the pores of the base material (1.1) are formed during the production.
  • the particles of boron compound (1.2) incorporated in the production system are positioned around the pores. Therefore, the boron compound (1.2) does not cause any blockage in the pores.
  • the boron compound (1.1) is present in powder form, and the boron compound (1.2) is dispersed in the polyol and added to the base material (1.1).
  • the ratio of the boron compound (1.2) added to the base material (1.1) is 40% to 45%.
  • the composite material (1) of the invention has wound healing properties as well as antibacterial properties. It may also be used in all areas that require hygiene.
  • the mixture of polyol and boron compound (1.2) of equal amounts during production of polyurethane base material (1.1) is added to the production system.
  • the ratio of the boron compound (1.2) in the composite material (1) is allowed to be at least 40% by adding the mixture obtained with the addition of boron compound (1.2) of 50% to the polyol to the base material (1.1).
  • the pores are not blocked and the polyurethane base material (1.1) is not lost, as a result it does not harden, as the boron compound (1.2) is added to the system at this ratio during the production of the polyurethane base material (1.1).
  • Table 1 provides the content of the composite material (1) and the percentages by weight of the content. Table 1. Chemical content of the composite material (1) and the percentages by weight therefor
  • the composite material (1.1) contains 50% boron compound (wound healing agent) (1.2) in 80% to 90% by weight of poly ether polyol (raw material for polyurethane) and/or 0% to 5% by weight of methylene chloride (foaming agent) and/or 0.5% to 3% of water (raw material for foaming reaction) and/or 0.05% to 0.5 by weight of tin octoate (polyurethane catalyst) and/or 0.001 to 0.01 by weight of 70% bis (dimethyl amino ethyl) ether diluted in 30% propylene glycol (foaming catalyst) and/or 0.001% to 0.04% by weight of 33% triethylene diamine 67% dipropylene glycol solution (gelling catalyst) and/or 0% to 0.1% by weight of %33 urea solution (cross linker) and/or 0% to 0.1% by weight of diethanol amine/triethanolamine (cross linker) and/or 0.1% to 0.8% by weight of polyether modified polysi
  • borax pentahydrate (Etibor-48) (Na 2 B 4 0 7 .5H 2 0), or borax decahydrate (Na 2 B 4 O 7 .10H 2 O), or boric acid (Etidot-67) (H3BO3), or anhydrous borax (Etibor-68) (Na 2 B 4 0 ?
  • the boron compound (1.2) is suspended in the polyether polyol contained in the base material (1.1).
  • the above-mentioned boron compounds (1.2) are prepared by suspending in the polyol and the solution thereof contains 50% by weight of boron compound (1) and 50% by weight of polyether polyol.
  • the base material (El) contains 40 to 45% by weight of boron compound (1.2).
  • the composite material (1) has the ability to heal wounds.
  • the composite material (1) has a therapeutic effect, such as healing wounds on the skin.
  • the composite material is produced according to the following method (100) steps:
  • the second step adding 50% boron compound (wound healing agent) (1.2) in 80% to 90% by weight of polyether polyol (raw material for polyurethane) and/or 0% to 5% by weight of methylene chloride (foaming agent) and/or 0.5% to 3% of water (raw material for foaming reaction) and/or 0.05% to 0.5 by weight of tin octoate (polyurethane catalyst) and/or 0.001 to 0.01 by weight of 70% bis (dimethyl amino ethyl) ether diluted in 30% propylene glycol (foaming catalyst) and/or 0.001% to 0.04% by weight of 33% triethylene diamine 67% dipropylene glycol solution (gelling catalyst) and/or 0% to 0.1% by weight of %33 urea solution (cross linker) and/or 0% to 0.1% by weight of diethanol amine/triethanolamine (cross linker) and/or 0.1% to 0.8% by weight of polyether modified polysiloxane
  • the third step forming the composite material by a reaction of the materials from the mixer in a tunnel.
  • the composite material (1) of the invention will be used in the fields such as medical, cleaning, mattress, upholstery (sofa), bras, and shoe insoles.
  • the invention may be used in dressings, patient cleansing sponges, bandages, cleansing sponges, sickbeds, normal beds, products in contact with people (bra, shoe insole), etc.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un matériau composite (1) comprenant un matériau de base (1.1) et un composé du bore (1.2) ajouté audit matériau de base (1.1) selon une proportion prédéterminée, ledit matériau composite comprenant un composé du bore (1.2) qui peut être présent à raison d'au moins 40 % par addition du mélange obtenu par mise en suspension de 50 % en poids du composé du bore (1.2) dans le polyétherpolyol au matériau de base (1.1).
PCT/TR2020/050461 2020-04-02 2020-05-28 Matériau composite formé à l'aide de bore au cours de la production d'un matériau de base en polyuréthane WO2021201792A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP20735248.5A EP4127043A1 (fr) 2020-04-02 2020-05-28 Matériau composite formé à l'aide de bore au cours de la production d'un matériau de base en polyuréthane

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR202005248 2020-04-02
TR2020/05248 2020-04-02

Publications (1)

Publication Number Publication Date
WO2021201792A1 true WO2021201792A1 (fr) 2021-10-07

Family

ID=71266784

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/TR2020/050461 WO2021201792A1 (fr) 2020-04-02 2020-05-28 Matériau composite formé à l'aide de bore au cours de la production d'un matériau de base en polyuréthane

Country Status (2)

Country Link
EP (1) EP4127043A1 (fr)
WO (1) WO2021201792A1 (fr)

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202703A1 (en) * 2003-04-09 2004-10-14 Bejersdorf Ag Antimicrobial wound covering article
WO2005052057A1 (fr) * 2003-11-25 2005-06-09 Nippon Polyurethane Industry Co., Ltd Procede de production d'une mousse de polyurethane flexible
US20080203348A1 (en) * 2004-07-22 2008-08-28 Fouad Laoutid Firestop Material
US8147857B2 (en) * 2004-12-21 2012-04-03 Bayer Innovation Gmbh Infection-resistant polyurethane foams, method for producing the same and use thereof in antiseptic wound dressings
US8263100B2 (en) * 2007-03-01 2012-09-11 Mölnlycke Health Care Ab Silver-containing foam structure
US20160051724A1 (en) * 2013-04-08 2016-02-25 Yeditepe Universitesi Polymer based hydrogel

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040202703A1 (en) * 2003-04-09 2004-10-14 Bejersdorf Ag Antimicrobial wound covering article
WO2005052057A1 (fr) * 2003-11-25 2005-06-09 Nippon Polyurethane Industry Co., Ltd Procede de production d'une mousse de polyurethane flexible
US20080203348A1 (en) * 2004-07-22 2008-08-28 Fouad Laoutid Firestop Material
US8147857B2 (en) * 2004-12-21 2012-04-03 Bayer Innovation Gmbh Infection-resistant polyurethane foams, method for producing the same and use thereof in antiseptic wound dressings
US8263100B2 (en) * 2007-03-01 2012-09-11 Mölnlycke Health Care Ab Silver-containing foam structure
US20160051724A1 (en) * 2013-04-08 2016-02-25 Yeditepe Universitesi Polymer based hydrogel

Also Published As

Publication number Publication date
EP4127043A1 (fr) 2023-02-08

Similar Documents

Publication Publication Date Title
US6238691B1 (en) Hydrogel wound dressing and the method of making and using the same
EP1159972B1 (fr) Pansements microbicides contenant des composés métalliques
US6861067B2 (en) Hydrogel wound dressing and the method of making and using the same
US7538257B2 (en) Fluid wound dressing comprising partially cured polyurethane
JP4984266B2 (ja) 銀結合抗菌性湿潤創傷被覆材を製造する方法及び該方法により製造された湿潤創傷被覆材
JPH07113067B2 (ja) 親水性の発泡組成物
JPH06192383A (ja) ポリウレタンフォームの製法
JPH07204260A (ja) ポリウレタンフォームから成る包帯
KR20130085245A (ko) 항균성 창상 피복재 및 그 제조방법
WO1999013923A2 (fr) Pansement d'hydrogel et procede de fabrication et d'utilisation de celui-ci
CN113456877B (zh) 有机硅泡沫医用敷料及其制备方法与应用
US10821203B2 (en) Composition and dressing with nitric oxide
AU2003243262A1 (en) Hydrophilic foam compositions having antimicrobial properties
CN100536929C (zh) 一种医用敷料的制备方法
WO2021201792A1 (fr) Matériau composite formé à l'aide de bore au cours de la production d'un matériau de base en polyuréthane
CN109880052A (zh) 一种医用绷带涂覆用聚氨酯树脂复合料的制备方法
JPH07508429A (ja) 創傷用包帯，創傷用被覆物もしくはキャリアマトリックス
CN112266454A (zh) 一种端羟基聚合物在制备多功能聚氨酯软泡敷料中的应用
WO2007033135A2 (fr) Procédé de fabrication d'agents hémostatiques et leurs utilisations
EP1558300A1 (fr) Pansement fluidique comprenant du polyurethanne partiellement durci
EP4338762A1 (fr) Procédé de production d'une composition d'hydrogel hautement absorbante à des fins médicales, en particulier pour le traitement de plaies
JPS6244258A (ja) 医療用生体表面被覆材
AU2002251838B2 (en) Hydrogel wound dressing,preparation and use thereof
JPH01124461A (ja) 医用材料及び傷の治療方法
WO2021029836A1 (fr) Mousse de polyuréthane souple modifiée au bore pour l'hygiène et son procédé de production

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20735248

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2020735248

Country of ref document: EP

Effective date: 20221102